These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 9792829)

  • 1. Limitations of differential display.
    Ledakis P; Tanimura H; Fojo T
    Biochem Biophys Res Commun; 1998 Oct; 251(2):653-6. PubMed ID: 9792829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differentially expressed genes in multidrug resistant variants of U-2 OS human osteosarcoma cells.
    Chano T; Mori K; Scotlandi K; Benini S; Lapucci C; Manara MC; Serra M; Picci P; Okabe H; Baldini N
    Oncol Rep; 2004 Jun; 11(6):1257-63. PubMed ID: 15138564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of P-glycoprotein expression and multidrug resistance by DNA cross-linking agents.
    Ihnat MA; Lariviere JP; Warren AJ; La Ronde N; Blaxall JR; Pierre KM; Turpie BW; Hamilton JW
    Clin Cancer Res; 1997 Aug; 3(8):1339-46. PubMed ID: 9815817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of real-time quantitative PCR to validate the results of cDNA array and differential display PCR technologies.
    Rajeevan MS; Ranamukhaarachchi DG; Vernon SD; Unger ER
    Methods; 2001 Dec; 25(4):443-51. PubMed ID: 11846613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single nucleotide polymorphisms in the multidrug resistance gene 1 (ABCB1): effects on its expression and clinicopathological characteristics in breast cancer patients.
    Vaclavikova R; Nordgard SH; Alnaes GI; Hubackova M; Kubala E; Kodet R; Mrhalova M; Novotny J; Gut I; Kristensen VN; Soucek P
    Pharmacogenet Genomics; 2008 Mar; 18(3):263-73. PubMed ID: 18300948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversal of multidrug resistance by small interfering double-stranded RNAs in ovarian cancer cells.
    Zhang T; Guan M; Jin HY; Lu Y
    Gynecol Oncol; 2005 May; 97(2):501-7. PubMed ID: 15863151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emergence of p53 mutant cisplatin-resistant ovarian carcinoma cells following drug exposure: spontaneously mutant selection.
    Righetti SC; Perego P; Corna E; Pierotti MA; Zunino F
    Cell Growth Differ; 1999 Jul; 10(7):473-8. PubMed ID: 10437915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Genetic diagnosis for drug resistance in cancers].
    Funato T; Fujimaki S; Fujiwara J; Miura T; Yoshida K; Kaku M; Sasaki T
    Rinsho Byori; 2000 Feb; 48(2):162-6. PubMed ID: 10804820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The selection of taxol resistance associated genes in ovarian cancer cell line by mRNA DD].
    Cheng G; Tian F; Li Y
    Zhonghua Yi Xue Za Zhi; 2000 Jul; 80(7):541-3. PubMed ID: 11798816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of the MRP and MDR1 multidrug resistance genes in small cell lung cancer.
    Campling BG; Young LC; Baer KA; Lam YM; Deeley RG; Cole SP; Gerlach JH
    Clin Cancer Res; 1997 Jan; 3(1):115-22. PubMed ID: 9815546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ankyrin repeat domain 1, ANKRD1, a novel determinant of cisplatin sensitivity expressed in ovarian cancer.
    Scurr LL; Guminski AD; Chiew YE; Balleine RL; Sharma R; Lei Y; Pryor K; Wain GV; Brand A; Byth K; Kennedy C; Rizos H; Harnett PR; deFazio A
    Clin Cancer Res; 2008 Nov; 14(21):6924-32. PubMed ID: 18980987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential display of m-RNAs in fish gonads by modified DD-PCR.
    Dakis D; Kouretas D
    In Vivo; 2002; 16(2):103-5. PubMed ID: 12073767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exogenous mutant p53 DNA enhanced cisplatin-induced apoptosis in TSGH-8301 human bladder cancer cells.
    Chang FL; Ling YF; Lai MD
    Anticancer Res; 2000; 20(1A):329-36. PubMed ID: 10769676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of genes whose expression is associated with cisplatin resistance in human ovarian carcinoma cells.
    Cheng TC; Manorek G; Samimi G; Lin X; Berry CC; Howell SB
    Cancer Chemother Pharmacol; 2006 Sep; 58(3):384-95. PubMed ID: 16404635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RNA profiling in peripheral blood cells by fluorescent differential display PCR.
    Steinau M; Rajeevan MS
    Methods Mol Biol; 2009; 496():211-22. PubMed ID: 18839113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic changes in the evolution of multidrug resistance for cultured human ovarian cancer cells.
    Buys TP; Chari R; Lee EH; Zhang M; MacAulay C; Lam S; Lam WL; Ling V
    Genes Chromosomes Cancer; 2007 Dec; 46(12):1069-79. PubMed ID: 17726699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Establishment of a human nasopharyngeal carcinoma drug-resistant cell line CNE2/DDP and screening of drug-resistant genes].
    Jiang RD; Zhang LX; Yue W; Zhu YF; Lu HJ; Liu X; Cen XT; Guan XY; Li CH
    Ai Zheng; 2003 Apr; 22(4):337-45. PubMed ID: 12703984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishment of hepatocellular carcinoma multidrug resistant monoclone cell line HepG2/mdr1.
    Chen YB; Yan ML; Gong JP; Xia RP; Liu LX; Li N; Lu SC; Zhang JG; Zeng DB; Xie JG; Yang JY; Yan LN
    Chin Med J (Engl); 2007 Apr; 120(8):703-7. PubMed ID: 17517188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Identification of genes related to cell phenotypic transition by differential display analysis].
    Sun AJ; Gao PJ; Liu JJ; Ji KD; Zhu DL
    Sheng Li Xue Bao; 2001 Dec; 53(6):435-9. PubMed ID: 11930221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of an ovarian carcinoma cell line resistant to cisplatin and flavopiridol.
    Bible KC; Boerner SA; Kirkland K; Anderl KL; Bartelt D; Svingen PA; Kottke TJ; Lee YK; Eckdahl S; Stalboerger PG; Jenkins RB; Kaufmann SH
    Clin Cancer Res; 2000 Feb; 6(2):661-70. PubMed ID: 10690552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.